202 related articles for article (PubMed ID: 24747978)
1. The effects of quetiapine on sleep in recovering alcohol-dependent subjects: a pilot study.
Chakravorty S; Hanlon AL; Kuna ST; Ross RJ; Kampman KM; Witte LM; Perlis ML; Oslin DW
J Clin Psychopharmacol; 2014 Jun; 34(3):350-4. PubMed ID: 24747978
[TBL] [Abstract][Full Text] [Related]
2. Long-term functioning and sleep quality in patients with major depressive disorder treated with extended-release quetiapine fumarate.
Sheehan DV; Locklear J; Svedsäter H; Datto C
Int Clin Psychopharmacol; 2012 Sep; 27(5):239-48. PubMed ID: 22859063
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the effects of extended release quetiapine fumarate monotherapy on sleep disturbance in patients with major depressive disorder: a pooled analysis of four randomized acute studies.
Trivedi MH; Bandelow B; Demyttenaere K; Papakostas GI; Szamosi J; Earley W; Eriksson H
Int J Neuropsychopharmacol; 2013 Sep; 16(8):1733-44. PubMed ID: 23673347
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial.
Liebowitz M; Lam RW; Lepola U; Datto C; Sweitzer D; Eriksson H
Depress Anxiety; 2010 Oct; 27(10):964-76. PubMed ID: 20734365
[TBL] [Abstract][Full Text] [Related]
5. Quetiapine improves visual hallucinations in Parkinson disease but not through normalization of sleep architecture: results from a double-blind clinical-polysomnography study.
Fernandez HH; Okun MS; Rodriguez RL; Malaty IA; Romrell J; Sun A; Wu SS; Pillarisetty S; Nyathappa A; Eisenschenk S
Int J Neurosci; 2009; 119(12):2196-205. PubMed ID: 19916848
[TBL] [Abstract][Full Text] [Related]
6. Randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder.
Katila H; Mezhebovsky I; Mulroy A; Berggren L; Eriksson H; Earley W; Datto C
Am J Geriatr Psychiatry; 2013 Aug; 21(8):769-84. PubMed ID: 23567397
[TBL] [Abstract][Full Text] [Related]
7. Quetiapine for primary insomnia: a double blind, randomized controlled trial.
Tassniyom K; Paholpak S; Tassniyom S; Kiewyoo J
J Med Assoc Thai; 2010 Jun; 93(6):729-34. PubMed ID: 20572379
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of extended release quetiapine fumarate monotherapy in elderly patients with major depressive disorder: secondary analyses in subgroups of patients according to baseline anxiety, sleep disturbance, and pain levels.
Montgomery SA; Altamura AC; Katila H; Datto C; Szamosi J; Eriksson H
Int Clin Psychopharmacol; 2014 Mar; 29(2):93-105. PubMed ID: 24162081
[TBL] [Abstract][Full Text] [Related]
9. Double-blind, randomized study of extended release quetiapine fumarate (quetiapine XR) monotherapy in older patients with generalized anxiety disorder.
Mezhebovsky I; Mägi K; She F; Datto C; Eriksson H
Int J Geriatr Psychiatry; 2013 Jun; 28(6):615-25. PubMed ID: 23070803
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of adjunct extended-release quetiapine fumarate on sleep disturbance and quality in patients with major depressive disorder and an inadequate response to on-going antidepressant therapy.
Bauer M; McIntyre RS; Szamosi J; Eriksson H
Int J Neuropsychopharmacol; 2013 Sep; 16(8):1755-65. PubMed ID: 23672772
[TBL] [Abstract][Full Text] [Related]
11. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
[TBL] [Abstract][Full Text] [Related]
12. Effects of once-daily extended release quetiapine fumarate (quetiapine XR) on quality of life and sleep in elderly patients with major depressive disorder.
Locklear JC; Svedsäter H; Datto C; Endicott J
J Affect Disord; 2013 Jul; 149(1-3):189-95. PubMed ID: 23639212
[TBL] [Abstract][Full Text] [Related]
13. Effect of quetiapine XR on depressive symptoms and sleep quality compared with lithium in patients with bipolar depression.
Kim SJ; Lee YJ; Lee YJ; Cho SJ
J Affect Disord; 2014 Mar; 157():33-40. PubMed ID: 24581825
[TBL] [Abstract][Full Text] [Related]
14. A human laboratory study of the effects of quetiapine on subjective intoxication and alcohol craving.
Ray LA; Chin PF; Heydari A; Miotto K
Psychopharmacology (Berl); 2011 Oct; 217(3):341-51. PubMed ID: 21487653
[TBL] [Abstract][Full Text] [Related]
15. Night locomotor activity and quality of sleep in quetiapine-treated patients with depression.
Todder D; Caliskan S; Baune BT
J Clin Psychopharmacol; 2006 Dec; 26(6):638-42. PubMed ID: 17110822
[TBL] [Abstract][Full Text] [Related]
16. Extended release quetiapine fumarate (quetiapine XR) monotherapy as maintenance treatment for generalized anxiety disorder: a long-term, randomized, placebo-controlled trial.
Katzman MA; Brawman-Mintzer O; Reyes EB; Olausson B; Liu S; Eriksson H
Int Clin Psychopharmacol; 2011 Jan; 26(1):11-24. PubMed ID: 20881846
[TBL] [Abstract][Full Text] [Related]
17. Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep.
Endicott J; Paulsson B; Gustafsson U; Schiöler H; Hassan M
J Affect Disord; 2008 Dec; 111(2-3):306-19. PubMed ID: 18774180
[TBL] [Abstract][Full Text] [Related]
18. Self-reported sedation profile of quetiapine extended-release and quetiapine immediate-release during 6-day initial dose escalation in bipolar depression: a multicenter, randomized, double-blind, phase IV study.
Riesenberg RA; Baldytcheva I; Datto C
Clin Ther; 2012 Nov; 34(11):2202-11. PubMed ID: 23059166
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, placebo-controlled trial of quetiapine in patients with bipolar disorder, mixed or depressed phase, and alcohol dependence.
Brown ES; Davila D; Nakamura A; Carmody TJ; Rush AJ; Lo A; Holmes T; Adinoff B; Caetano R; Swann AC; Sunderajan P; Bret ME
Alcohol Clin Exp Res; 2014 Jul; 38(7):2113-8. PubMed ID: 24976394
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalised anxiety disorder: an analysis of pooled data from three 8-week placebo-controlled studies.
Stein DJ; Bandelow B; Merideth C; Olausson B; Szamosi J; Eriksson H
Hum Psychopharmacol; 2011 Dec; 26(8):614-28. PubMed ID: 22143997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
